OHSU Knight Cancer Institute, Tualatin — Tualatin, Oregon

OHSU Knight Cancer Institute, Tualatin is a clinical research site located in Tualatin, Oregon, United States 97062.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

OHSU Knight Cancer Institute, Tualatin has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: HER2-positive Breast Cancer, Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for OHSU Knight Cancer Institute, Tualatin?

OHSU Knight Cancer Institute, Tualatin has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has OHSU Knight Cancer Institute, Tualatin conducted?

OHSU Knight Cancer Institute, Tualatin has 2 clinical trials on record, with 2 currently active. Their work covers HER2-positive Breast Cancer, Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung.

Is OHSU Knight Cancer Institute, Tualatin accredited by Crixeo Health?

OHSU Knight Cancer Institute, Tualatin has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about OHSU Knight Cancer Institute, Tualatin?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.